Cargando…
Improving community participation in clinical trials in Ghana; factors to consider
INTRODUCTION: Clinical trials are an essential part of drug and vaccine development, as well as the development of new biomedical devices, and medical procedures. Successful enrolment of human volunteers is important to the success of any clinical trial anywhere around the globe. Enrolment is howeve...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574414/ https://www.ncbi.nlm.nih.gov/pubmed/36262802 http://dx.doi.org/10.1016/j.conctc.2022.101012 |
_version_ | 1784811100528705536 |
---|---|
author | Appeaning, Mark Owusu-Asante, Helen Kwofie, Samuel Arhin, George Asamoah, Andrew Oppong Ali, Tawfic Amponsah, Reginald Roland |
author_facet | Appeaning, Mark Owusu-Asante, Helen Kwofie, Samuel Arhin, George Asamoah, Andrew Oppong Ali, Tawfic Amponsah, Reginald Roland |
author_sort | Appeaning, Mark |
collection | PubMed |
description | INTRODUCTION: Clinical trials are an essential part of drug and vaccine development, as well as the development of new biomedical devices, and medical procedures. Successful enrolment of human volunteers is important to the success of any clinical trial anywhere around the globe. Enrolment is however affected by a number of factors including knowledge, attitudes, and perceptions (KAPs). We aimed to determine factors that are deemed important in improving participation in clinical trials within a Ghanaian community. METHOD: This was a cross-sectional study that employed a structured questionnaire within the New Juaben South Municipal Assembly (NJSMA). Participants who were 18 years and above were included in this study. There were a total of 639 participants in this study. Participants’ demographics were collected and various questions were asked to assess their KAP towards participation in clinical trials. RESULTS: The mean age of participants was 29.03 ± 8.95 years, there were more males (51.96%) than females, 42.35% had tertiary education, 38.03% were artisans, 74.80% were Christians and 14.40% had previously participated in a clinical trial. Participants had average knowledge about clinical trials (CT) with a mean score of 7.56 ± 1.76 (63%). A significant association between knowledge levels and education was observed (χ2 = 100.3, p < 0.0001). Helping in advancing the medical knowledge was the key reason for participation in CT while mistrust of the medical system was the key setback in participation in CT. There was a generally positive attitude and a neutral perception towards participation in CTs. CONCLUSION: Groups intending to conduct CT should highlight the benefits of CT and address the perception of mistrust in the conduct of CTs in their education and sensitization programs before initiation of CTs in Ghana. |
format | Online Article Text |
id | pubmed-9574414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95744142022-10-18 Improving community participation in clinical trials in Ghana; factors to consider Appeaning, Mark Owusu-Asante, Helen Kwofie, Samuel Arhin, George Asamoah, Andrew Oppong Ali, Tawfic Amponsah, Reginald Roland Contemp Clin Trials Commun Article INTRODUCTION: Clinical trials are an essential part of drug and vaccine development, as well as the development of new biomedical devices, and medical procedures. Successful enrolment of human volunteers is important to the success of any clinical trial anywhere around the globe. Enrolment is however affected by a number of factors including knowledge, attitudes, and perceptions (KAPs). We aimed to determine factors that are deemed important in improving participation in clinical trials within a Ghanaian community. METHOD: This was a cross-sectional study that employed a structured questionnaire within the New Juaben South Municipal Assembly (NJSMA). Participants who were 18 years and above were included in this study. There were a total of 639 participants in this study. Participants’ demographics were collected and various questions were asked to assess their KAP towards participation in clinical trials. RESULTS: The mean age of participants was 29.03 ± 8.95 years, there were more males (51.96%) than females, 42.35% had tertiary education, 38.03% were artisans, 74.80% were Christians and 14.40% had previously participated in a clinical trial. Participants had average knowledge about clinical trials (CT) with a mean score of 7.56 ± 1.76 (63%). A significant association between knowledge levels and education was observed (χ2 = 100.3, p < 0.0001). Helping in advancing the medical knowledge was the key reason for participation in CT while mistrust of the medical system was the key setback in participation in CT. There was a generally positive attitude and a neutral perception towards participation in CTs. CONCLUSION: Groups intending to conduct CT should highlight the benefits of CT and address the perception of mistrust in the conduct of CTs in their education and sensitization programs before initiation of CTs in Ghana. Elsevier 2022-10-03 /pmc/articles/PMC9574414/ /pubmed/36262802 http://dx.doi.org/10.1016/j.conctc.2022.101012 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Appeaning, Mark Owusu-Asante, Helen Kwofie, Samuel Arhin, George Asamoah, Andrew Oppong Ali, Tawfic Amponsah, Reginald Roland Improving community participation in clinical trials in Ghana; factors to consider |
title | Improving community participation in clinical trials in Ghana; factors to consider |
title_full | Improving community participation in clinical trials in Ghana; factors to consider |
title_fullStr | Improving community participation in clinical trials in Ghana; factors to consider |
title_full_unstemmed | Improving community participation in clinical trials in Ghana; factors to consider |
title_short | Improving community participation in clinical trials in Ghana; factors to consider |
title_sort | improving community participation in clinical trials in ghana; factors to consider |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574414/ https://www.ncbi.nlm.nih.gov/pubmed/36262802 http://dx.doi.org/10.1016/j.conctc.2022.101012 |
work_keys_str_mv | AT appeaningmark improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider AT owusuasantehelen improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider AT kwofiesamuel improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider AT arhingeorge improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider AT asamoahandrewoppong improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider AT alitawfic improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider AT amponsahreginaldroland improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider |